Admin

Is Stem Cell Therapy Right for Your Knee Osteoarthritis? A Candidacy Guide If you’ve been told you have knee osteoarthritis, you’ve probably already come across the phrase “stem cell therapy” while researching your options. It’s a term that gets used loosely online, often alongside promises that sound too good to be true. Before considering stem cell therapy for knee osteoarthritis, you need a clear, honest answer to one question. Is this treatment appropriate for the specific stage of arthritis in your knee? That answer depends on how advanced your joint damage is — and that’s exactly what this guide walks you through.   The Problem: Living with Knee Osteoarthritis and Weighing Your Options Knee osteoarthritis develops gradually. Many patients describe the same pattern: stiffness first thing in the morning, a dull ache after a long day on their feet. Over time, this often grows into a hesitation around stairs or long walks.   Some have already tried physiotherapy, weight management, and anti-inflammatory medication with only partial relief. Others have been told that a knee replacement is “in the future” but aren’t ready for surgery yet. They want to know what — if anything — can be done in the meantime.   It’s natural to have questions before considering any newer treatment, especially one you’ve mostly encountered through advertisements or social media rather than a medical consultation. A common concern patients raise is whether stem cell therapy can genuinely help arthritis, or whether it only works for younger patients with milder joint wear.   What Is Stem Cell Therapy for Knee Osteoarthritis? Stem cell therapy for the knee typically involves concentrating cells with regenerative potential. These are usually drawn from the patient’s own bone marrow or fat tissue, then injected into the joint. The intent is to influence the joint’s inflammatory environment and support the health of the remaining cartilage, rather than to regrow a worn-out joint surface entirely. It’s important to separate this from cartilage transplantation or joint replacement, which are different procedures altogether. Stem cell therapy sits within the broader category of joint preservation procedures — options considered before more invasive surgery becomes necessary, not a substitute for it once damage is advanced. It’s one part of a wider regenerative medicine approach used alongside other options depending on what a patient’s joint actually needs. The scientific evidence in this area is still developing. Some patients with early-to-moderate osteoarthritis report meaningful improvement in pain and function. Results in advanced, “bone-on-bone” arthritis tend to be more limited, since there is little healthy cartilage left for the treatment to support. It’s also worth knowing where this stands in India specifically. The Indian Council of Medical Research’s evidence-basedguidelines currently classify stem cell therapy for orthopaedic conditions as not yet a standard or routine therapy. That means it isn’t a default first-line treatment, but one considered on a case-by-case basis. ICMR’s own review of the published evidence found mostly small studies. One 56-patient trial, for example, found stem cells performed better than a comparison injection when combined with corrective knee surgery. That trial wasn’t blinded, though, and ICMR’s assessment is that evidence at this level doesn’t yet meet the bar for standard use. This is precisely why candidacy assessment matters more than the procedure itself.   Who Is a Good Candidate for Stem Cell Therapy for Knee Osteoarthritis? Candidacy for stem cell therapy in knee osteoarthritis is generally assessed against a few factors: Severity of joint damage, staged the same way as our clinic’s other resources (Grade 1–4).Grade 1 (very mild wear) through early Grade 3 (moderate cartilage loss, some healthy tissue remaining) are generally the better candidates. By Grade 4 — bone-on-bone arthritis — there’s little healthy cartilage left for stem cell therapy to support, and joint replacement typically becomes the more effective option. Response to conservative treatment.Most patients considering this option have already tried physiotherapy, weight management, activity modification, or medication. Overall joint alignment and stability.Significant deformity or ligament instability may need to be addressed separately, or may reduce how much benefit regenerative treatment alone can offer. General health factors, since certain medical conditions and medications can affect suitability.   None of this can be assessed from a description alone — it requires a clinical examination and imaging to see exactly how much cartilage and joint space remain. A treatment plan should never be built around a single online description of “stem cell therapy.” The right approach depends entirely on your knee, not a generic protocol. See our full overview of knee osteoarthritistreatment options for how this fits alongside conservative care and surgery.   What does a candidacy assessment actually involve? While the exact process varies by clinic, a thorough candidacy assessment for stem cell therapy generally includes a few consistent steps. First, a review of your symptom history and what conservative treatments you’ve already tried. Second, a physical examination of the knee’s alignment, stability, and range of motion. Third, imaging — typically an X-ray, sometimes an MRI — to see the actual extent of cartilage loss and joint space narrowing.   Only after these three steps can severity be graded and candidacy genuinely assessed, rather than assumed from symptoms alone. For a closer look at how arthritis severity is staged and what non-surgical options exist at each stage, see CanKnee Arthritis Be Treated Without Surgery?   Who should not consider stem cell therapy? Stem cell therapy is not for everyone. Several health and lifestyle factors can make stem cell therapy unsuitable or complicate it further — each one is weighed case-by-case during your evaluation, not applied as a blanket rule:   Any history of cancer, whether active or previously treated.Stem cell therapy works by encouraging cell growth to support healing. That same growth-promoting effect could, in theory, also encourage the growth of cancer cells. Because of this risk, any history of cancer rules out candidacy, regardless of how long ago it was treated. Active systemic infection.An infection anywhere in the body raises the risk of introducing it into the joint during injection, and can interfere with how well the